02.04.2020 • News

Nouryon Expands Peroxides Partnership with Sumitomo

Nouryon Expands Peroxides Partnership with Sumitomo (c) Nouryon
Nouryon Expands Peroxides Partnership with Sumitomo (c) Nouryon

Nouryon is expanding its partnership with Sumitomo Chemical to include a manufacturing facility the Japanese company is building at its site in Oita.

The new plant, to be owned and operated by Sumitomo, will supply 1,3-diisopropanolbenzene (DIOL), which is a key raw material for Nouryon’s Perkadox 14 organic peroxide. Start-up is due in 2021.

Perkadox 14 is used to make a variety of elastomeric products, including shoe soles, yoga mats and other rubber goods.

 “We have a strong relationship with Sumitomo, which has supplied DIOL to us from Chiba for the past four years,” said Alain Rynwalt, vice president of polymer catalysts at Nouryon. “In response to increased customer demand for our organic peroxides in Asia, we worked with Sumitomo to develop a plant in Oita to help ensure security of supply.”

Johan Landfors, Nouryon’s president of technology solutions, added that the agreement is “a great example of partnering with a supplier to support our strategy of expanding in attractive growth markets.”

Nouryon produces Perkadox 14 at Mons, Belgium, and Ningbo, China, where it completed a project last June that lifted capacity by 25%.

Company

Logo:

Nouryon

Christian Neefestraat 2
1077 WW Amsterdam
Netherlands

Company contact







Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.